Page last updated: 2024-08-23

pergolide and Heart Valve Diseases

pergolide has been researched along with Heart Valve Diseases in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	52 (86.67)	29.6817
2010's	7 (11.67)	24.3611
2020's	1 (1.67)	2.80

Authors

Authors	Studies
Donis, N; Dulgheru, R; Fillet, M; Hego, A; Hulin, A; Lancellotti, P; Maréchal, P; Nchimi, A; Nguyen, ML; Oury, C; Tridetti, J	1
Jobic, Y; Tribouilloy, C	1
Bianchini, E; Bramanti, P; Cilia, R; Ciurleo, R; de Luise, C; Di Lorenzo, G; Ilardi, M; Italiano, D; Pezzoli, G; Polimeni, G; Rijnbeek, P; Ross, D; Stocchi, F; Sturkenboom, M; Trifirò, G; Vacca, L; Zanettini, R	1
Andrejak, M; Dupuy, D; Gérard, P; Godefroy, O; Lesbre, JP	1
Duong-Hua, M; Lang, A; Marras, C; Rochon, P; Sykora, K; Zadikoff, C	1
Cosyns, B; Droogmans, S; Van Camp, G	1
Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I	1
Aydemir, T; Bader, H; Cetin, S; Kizkin, S; Meral, H; Ozben, B; Ozben, S; Ozer, F; Ozturk, O; Tiras, R	1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C	1
Andersohn, F; Garbe, E	1
Sherlock, M; Steeds, R; Toogood, AA	1
Berendse, H; Bloem, BR; Boon, AJ; de Koning-Tijssen, MA; Hovestadt, A; Nijssen, PC; van Hilten, JJ; van Laar, T; Weber, WE	1
Caveliers, V; Cosyns, B; Degaillier, C; Droogmans, S; Franken, PR; Garbar, C; Hernot, S; Lahoutte, T; Pipeleers-Marichal, M; Roosens, B; Schoors, D; Van Camp, G; Weytjens, C	1
Pullan, PT	1
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH	1
Antonini, A; Gatto, G; Gentile, R; Pezzoli, G; Tesei, S; Zanettini, R	2
Kubota, K; Ooba, N; Yamaguchi, T	1
Ikeda, S; Ishizaki, T; Morikawa, K; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H	1
Albers, KB; Berkheimer, SB; Fross, RD; Jang, JJ; Krishnaswami, A; Kwai Ben, VC; Vandeneeden, SK	1
Dorsher, PT; Edwards, WD; Freeman, WD; Safford, RE; Van Gerpen, J	1
Lanier, WL	1
Beitz, JG; Flowers, CM; Lu, SL; Racoosin, JA	1
Cosyns, B; Flamez, A; Goldstein, J; Perdaens, C; Schoors, D; Van Camp, G	1
Bagheri, H; Montastruc, JL; Pathak, A	1
Cosyns, B; De Sutter, J; Decoodt, P; Flamez, A; Moerman, C; Muyldermans, L; Santens, P; Schoors, D; Van Camp, G; Van Zandijcke, M; Weytjens, C	1
Grosset, DG; Grosset, KA	1
Bagheri, H; Montastruc, JL; Pathak, A; Rascol, O	2
Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H	1
Baseman, DG; Baseman, JG; Dewey, RB; Laskar, SR; O'Suilleabhain, PE; Reimold, SC	1
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP	1
Horowski, R; Jähnichen, S; Pertz, HH	1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P	1
Ludin, HP	1
Bonnet, AM; Corvol, JC; Schüpbach, M	1
Chung, EJ; Kim, JY; Lee, WY; Yoon, WT	1
Lang, A; Rochon, P; Zadikoff, C	1
Johnston, W; Martin, WR; Puttagunta, L; Scozzafava, J; Takahashi, J	1
Chung, EJ; Kim, JY; Lee, WY; Park, SW	1
Kaplan, J; Waller, EA	1
Burger, E; Härtter, S; Kvernmo, T	1
Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH	1
Roth, BL	1
Andersohn, F; Garbe, E; Haverkamp, W; Schade, R; Suissa, S	1
Erginöz, E; Kenangil, G; Koldas, L; Ozekmekçi, S; Sahin, T	1
Dewey, RB; O'Suilleabhain, PE; Reimold, SC	1
Altschuler, EL; Kast, RE	1
Linkova, H; Penicka, M; Ruzicka, E	1
Cavazzoni, PA; Dellva, MA; Jungemann, ME; Lledó, A; Royer, MG; Simmons, VE; Strombom, IM; Wilkie, JL	1
Senol, MG; Togrol, RE	1
Bossuyt, A; Caveliers, V; Cosyns, B; Droogmans, S; Franken, PR; Garbar, C; Lahoutte, T; Pipeleers-Marichal, M; Schoors, D; Van Camp, G; Weytjens, C	1
Fuhrmann, JT; Simonis, G; Strasser, RH	1
Grandas, F	1
Antonini, A; Poewe, W	1
Línková, H; Nováková, L; Penicka, M; Roth, J; Růzicka, E; Ulmanová, O	1
Fourrier-Reglat, A; Gregoire, F; Haramburu, F; Moore, N; Pariente, A	1
Agid, Y; Anzouan-Kacou, JB; Bonnet, AM; Corvol, JC; Fauveau, E; Girault, C; Isnard, R; Lacomblez, L; Lebrun-Vignes, B; Lechat, P	1

Reviews

10 review(s) available for pergolide and Heart Valve Diseases

Article	Year
Drug-induced fibrotic valvular heart disease. Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689 Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents	2009
[Are there innovations in the treatment of Parkinson's disease?]. Praxis, 2004, Nov-03, Volume: 93, Issue:45 Topics: Antiparkinson Agents; Cannabis; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dopamine Agonists; Heart Valve Diseases; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pergolide; Phenylcarbamates; Placebos; Rivastigmine; Time Factors	2004
[Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations]. Revue neurologique, 2005, Volume: 161, Issue:6-7 Topics: Antiparkinson Agents; Heart Valve Diseases; Humans; Pergolide	2005
Cardiac valvulopathy associated with pergolide use. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:1 Topics: Antiparkinson Agents; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2006
Pergolide-associated valvular heart disease. Comprehensive therapy, 2006,Summer, Volume: 32, Issue:2 Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Valve Diseases; Humans; Pergolide; Prevalence; Pulmonary Fibrosis; Retroperitoneal Fibrosis	2006
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine	2006
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13 Topics: Antiparkinson Agents; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Drug Combinations; Echocardiography; Ergolines; Ergot Alkaloids; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Product Surveillance, Postmarketing	2007
[Cardiac valvulopathy and dopamine agonist]. Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:10 Topics: Antiparkinson Agents; Biomedical Research; Dopamine Agonists; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Pergolide	2007
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. The Lancet. Neurology, 2007, Volume: 6, Issue:9 Topics: Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2007
Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis. Archives of neurology, 2007, Volume: 64, Issue:12 Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Middle Aged; Mitral Valve Insufficiency; Odds Ratio; Parkinson Disease; Pergolide; Prospective Studies; Risk Factors; Tricuspid Valve Insufficiency	2007

Trials

3 trial(s) available for pergolide and Heart Valve Diseases

Article	Year
Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:1 Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Female; Heart Valve Diseases; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Single-Blind Method; Young Adult	2009
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency	2007
Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide. Journal of neurology, 2007, Volume: 254, Issue:11 Topics: Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Valve Diseases; Humans; Incidence; Male; Middle Aged; Mitral Valve; Parkinson Disease; Pergolide	2007

Other Studies

47 other study(ies) available for pergolide and Heart Valve Diseases

Article	Year
Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International journal of molecular sciences, 2020, Jun-03, Volume: 21, Issue:11 Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cluster Analysis; Dexfenfluramine; Enzyme Activation; Extracellular Matrix; Female; Gene Expression Regulation; Heart Valve Diseases; Homeostasis; MicroRNAs; p38 Mitogen-Activated Protein Kinases; Pergolide; Rabbits; Sequence Analysis, RNA; Serotonin; Transcriptome; Transforming Growth Factor beta; Tricuspid Valve	2020
[Drug-induced valve heart disease]. La Revue du praticien, 2016, Volume: 66, Issue:8 Topics: Cabergoline; Dopamine Agonists; Heart Valve Diseases; Humans; Pergolide	2016
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy. Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:6 Topics: Aged; Antiparkinson Agents; Cabergoline; Cohort Studies; Echocardiography; Ergolines; Female; Guideline Adherence; Heart Valve Diseases; Heart Valves; Humans; Incidence; Italy; Male; Middle Aged; Parkinson Disease; Pergolide; Practice Guidelines as Topic; Prevalence; Retrospective Studies; Risk Factors; Supranuclear Palsy, Progressive	2015
Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications. Journal of neurology, 2008, Volume: 255, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Confidence Intervals; Dopamine Agonists; Electrocardiography; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Odds Ratio; Parkinson Disease; Pergolide; Retrospective Studies	2008
Pergolide associated cardiac valvulopathy based on Ontario administrative data. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Databases, Factual; Dopamine Agonists; Female; Health Services Administration; Heart Failure; Heart Valve Diseases; Humans; Levodopa; Male; Ontario; Parkinson Disease; Pergolide	2008
Pergolide and valvular heart disease: the lower the better? European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2008, Volume: 9, Issue:6 Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Practice Guidelines as Topic; Restless Legs Syndrome; Ultrasonography	2008
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2008
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2 Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors	2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States	2009
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do. Heart (British Cardiac Society), 2009, Volume: 95, Issue:7 Topics: Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Heart Valve Diseases; Heart Valves; Humans; Hyperprolactinemia; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency	2009
[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide]. Nederlands tijdschrift voor geneeskunde, 2009, Jan-17, Volume: 153, Issue:3 Topics: Dopamine Agonists; Echocardiography; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Risk Factors	2009
Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:6 Topics: Animals; Blood Pressure; Body Weight; Cyproheptadine; Dopamine Agonists; Drug Interactions; Echocardiography; Fibrosis; Heart Valve Diseases; Heart Valves; Male; Myocytes, Cardiac; Pergolide; Rats; Rats, Wistar; Serotonin Antagonists	2009
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy. Internal medicine journal, 2009, Volume: 39, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography	2009
Regression of cardiac valvulopathy related to ergot-derived dopamine agonists. Cardiovascular therapeutics, 2011, Volume: 29, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Italy; Male; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Ultrasonography	2011
The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. Drug safety, 2011, Apr-01, Volume: 34, Issue:4 Topics: Cabergoline; Databases, Factual; Dopamine Agonists; Drug Prescriptions; Drug Utilization Review; Ergolines; Government Regulation; Heart Valve Diseases; Humans; Insurance Claim Review; Japan; Legislation, Drug; Parkinson Disease; Pergolide; Regression Analysis; Ultrasonography	2011
Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:7 Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Drug Labeling; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Incidence; Japan; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Risk Factors	2011
Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation. Pharmacoepidemiology and drug safety, 2012, Volume: 21, Issue:3 Topics: Aged; California; Cross-Sectional Studies; Databases, Factual; Dopamine Agonists; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Multivariate Analysis; Pergolide; Predictive Value of Tests; Prospective Studies; Time Factors	2012
Combined pergolide-associated valvular heart disease and achilles tendon contractures. Acta medica academica, 2012, Volume: 41, Issue:2 Topics: Achilles Tendon; Aged; Contracture; Dopamine Agonists; Female; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2012
Additional insights into pergolide-associated valvular heart disease. Mayo Clinic proceedings, 2003, Volume: 78, Issue:6 Topics: Adverse Drug Reaction Reporting Systems; Dopamine Agonists; Evidence-Based Medicine; Fibrosis; Heart Valve Diseases; Humans; Incidence; Pergolide; Registries; Serotonin	2003
The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease. Mayo Clinic proceedings, 2003, Volume: 78, Issue:6 Topics: Adverse Drug Reaction Reporting Systems; Belgium; Denmark; Dopamine Agonists; Finland; Heart Valve Diseases; Humans; Pergolide; Registries; United Kingdom; United States; United States Food and Drug Administration	2003
Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide. Neurology, 2003, Sep-23, Volume: 61, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aortic Valve Insufficiency; Echocardiography; Fatal Outcome; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency	2003
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis]. Revue neurologique, 2004, Volume: 160, Issue:1 Topics: Dopamine Agonists; Ergotamine; Fibrosis; Heart Diseases; Heart Valve Diseases; Humans; Pergolide; Vasoconstrictor Agents	2004
Valvular health disease with pergolide. Prescrire international, 2003, Volume: 12, Issue:68 Topics: Antiparkinson Agents; Heart Valve Diseases; Humans; Pergolide	2003
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet (London, England), 2004, Apr-10, Volume: 363, Issue:9416 Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	2004
Pergolide in Parkinson's disease: time for a change? Lancet (London, England), 2004, Jun-05, Volume: 363, Issue:9424 Topics: Antiparkinson Agents; Dopamine Agonists; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2004
New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6 Topics: Disclosure; Dopamine Agonists; Ergot Alkaloids; Health Education; Heart Valve Diseases; Humans; International Cooperation; Pergolide; Risk Factors	2004
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6 Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide	2004
Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cardiomyopathy, Restrictive; Cohort Studies; Disease Progression; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pericarditis; Pulmonary Valve Insufficiency; Single-Blind Method; Tricuspid Valve Insufficiency; Ultrasonography	2004
Cardiopulmonary complications of ergot-derivative dopamine agonists. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10 Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone	2004
Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Dopamine Agents; Fibroblasts; Fibrosis; Heart Valve Diseases; Humans; Myoblasts; Parkinson Disease; Pergolide; Receptors, Serotonin	2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2004
Dopaminagonists and fibrotic valvular heart disease: further considerations. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Dopamine Agonists; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2004
Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:4 Topics: Antiparkinson Agents; Dose-Response Relationship, Drug; Echocardiography; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	2006
Valvular heart disease in pergolide-treated Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:1 Topics: Aged; Antiparkinson Agents; Female; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2006
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values	2006
Drugs and valvular heart disease. The New England journal of medicine, 2007, Jan-04, Volume: 356, Issue:1 Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Pergolide; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists	2007
Dopamine agonists and the risk of cardiac-valve regurgitation. The New England journal of medicine, 2007, Jan-04, Volume: 356, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cabergoline; Case-Control Studies; Cohort Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists	2007
Valvular heart disease and the use of dopamine agonists for Parkinson's disease. The New England journal of medicine, 2007, Jan-04, Volume: 356, Issue:1 Topics: Aged; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Parkinson Disease; Pergolide; Regression Analysis; Risk; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Ultrasonography	2007
Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:4 Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Tricuspid Valve Insufficiency	2007
Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease. Archives of neurology, 2007, Volume: 64, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Echocardiography; Female; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2007
Parkinson's drugs linked to heart valve trouble. Harvard heart letter : from Harvard Medical School, 2007, Volume: 17, Issue:8 Topics: Antiparkinson Agents; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Pergolide	2007
Dopamine agonists and valvular heart disease. The New England journal of medicine, 2007, Apr-19, Volume: 356, Issue:16 Topics: Antipsychotic Agents; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Methysergide; Pergolide; Receptor, Serotonin, 5-HT2B; Retroperitoneal Fibrosis; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists	2007
Dopamine agonists and valvular heart disease. The New England journal of medicine, 2007, Apr-19, Volume: 356, Issue:16 Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	2007
Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. European journal of neurology, 2007, Volume: 14, Issue:6 Topics: Antiparkinson Agents; Awareness; Data Collection; Europe; Female; Heart Valve Diseases; Humans; International Cooperation; Male; Neurology; Pergolide; Practice Patterns, Physicians'	2007
Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study. Neurology, 2007, Jul-03, Volume: 69, Issue:1 Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Parkinson Disease; Patient Selection; Pergolide; Pramipexole; Research Design; Sex Factors	2007
In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. European heart journal, 2007, Volume: 28, Issue:17 Topics: Animals; Disease Models, Animal; Dopamine Agonists; Echocardiography; Heart Valve Diseases; Male; Pergolide; Rats; Rats, Wistar	2007
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug safety, 2007, Volume: 30, Issue:10 Topics: Adverse Drug Reaction Reporting Systems; Antibodies, Monoclonal; Antipsychotic Agents; Antirheumatic Agents; Databases, Factual; Dopamine Agonists; France; Heart Valve Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Odds Ratio; Pergolide; Prejudice; Product Surveillance, Postmarketing; Rhabdomyolysis; Stroke; Tuberculosis	2007